Jason Bednar
Stock Analyst at Piper Sandler
(2.30)
# 2,668
Out of 5,147 analysts
201
Total ratings
42.67%
Success rate
-2%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICUI ICU Medical | Maintains: Overweight | $172 → $178 | $150.58 | +18.21% | 4 | Feb 20, 2026 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $113 → $106 | $77.18 | +37.34% | 15 | Feb 18, 2026 | |
| BDX Becton, Dickinson and Company | Reiterates: Neutral | $205 → $170 | $176.48 | -3.67% | 13 | Feb 10, 2026 | |
| NVST Envista Holdings | Reiterates: Neutral | $21 → $25 | $29.21 | -14.41% | 15 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $200 → $220 | $190.10 | +15.73% | 33 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $91 → $94 | $84.27 | +11.55% | 2 | Jan 30, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $47.51 | +5.24% | 1 | Jan 12, 2026 | |
| SHC Sotera Health Company | Upgrades: Overweight | $17 → $24 | $16.25 | +47.69% | 4 | Jan 9, 2026 | |
| COO The Cooper Companies | Reiterates: Overweight | $83 → $94 | $83.67 | +12.35% | 15 | Dec 5, 2025 | |
| SOLV Solventum | Maintains: Overweight | $94 → $98 | $74.20 | +32.08% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $4 | $4.77 | -16.14% | 8 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $175.35 | +19.76% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $9 → $2.5 | $1.58 | +58.23% | 12 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $13.67 | +148.72% | 11 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $14.68 | +8.99% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $82.39 | -6.54% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $4.37 | +2.97% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $252.35 | +5.01% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $3.40 | +76.47% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $7.76 | -9.79% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $20 | $0.96 | +1,980.95% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $503.51 | -26.12% | 4 | Jan 3, 2024 |
ICU Medical
Feb 20, 2026
Maintains: Overweight
Price Target: $172 → $178
Current: $150.58
Upside: +18.21%
Merit Medical Systems
Feb 18, 2026
Maintains: Overweight
Price Target: $113 → $106
Current: $77.18
Upside: +37.34%
Becton, Dickinson and Company
Feb 10, 2026
Reiterates: Neutral
Price Target: $205 → $170
Current: $176.48
Upside: -3.67%
Envista Holdings
Feb 6, 2026
Reiterates: Neutral
Price Target: $21 → $25
Current: $29.21
Upside: -14.41%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $200 → $220
Current: $190.10
Upside: +15.73%
GE HealthCare Technologies
Jan 30, 2026
Maintains: Overweight
Price Target: $91 → $94
Current: $84.27
Upside: +11.55%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $47.51
Upside: +5.24%
Sotera Health Company
Jan 9, 2026
Upgrades: Overweight
Price Target: $17 → $24
Current: $16.25
Upside: +47.69%
The Cooper Companies
Dec 5, 2025
Reiterates: Overweight
Price Target: $83 → $94
Current: $83.67
Upside: +12.35%
Solventum
Nov 7, 2025
Maintains: Overweight
Price Target: $94 → $98
Current: $74.20
Upside: +32.08%
Aug 7, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.77
Upside: -16.14%
Aug 6, 2025
Maintains: Overweight
Price Target: $200 → $210
Current: $175.35
Upside: +19.76%
Jul 31, 2025
Downgrades: Neutral
Price Target: $9 → $2.5
Current: $1.58
Upside: +58.23%
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $13.67
Upside: +148.72%
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $14.68
Upside: +8.99%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $82.39
Upside: -6.54%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $4.37
Upside: +2.97%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $252.35
Upside: +5.01%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $3.40
Upside: +76.47%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $7.76
Upside: -9.79%
Aug 7, 2024
Maintains: Overweight
Price Target: $70 → $20
Current: $0.96
Upside: +1,980.95%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $503.51
Upside: -26.12%